Tags: Rodin Therapeutics


Advancing Epigenetics: A New Approach to Treating Alzheimer’s Disease

Dr. Howard Fillit discusses epigenetic treatments, one of the newest and most promising areas of our portfolio. 


Virtual Biotechs Maximize Lean Drug Discovery Budgets

Investing in "virtual biotechs" is an efficient way to fund high-risk and high-reward Alzheimer's research.